Drug repurposing declines as medicines age, especially when long trials shrink their remaining patent lives.
Drug repurposing declines as medicines age, especially when long trials shrink their remaining patent lives.
More from this article
See all →Thalidomide destroys a cancer-causing protein through the same biological tagging process involved…
Moxidectin began as a veterinary dewormer before a nonprofit-funded trial found it cured 70% of…
In SURMOUNT-1, tirzepatide reduced prediabetes progression to type 2 diabetes by 94% over three…
Today’s longer-lasting GLP-1 drugs trace back to a peptide discovered in Gila monsters.
Exendin-4 lasts for hours, while natural human GLP-1 lasts minutes because one changed amino acid…
Xanomeline reduced hallucinations in dementia trials before researchers developed it as a…
Gila monster venom contains Exendin-4, a peptide that resembles human GLP-1 and activates the same…
Most people begin regaining weight after stopping GLP-1 drugs, while an 18-month trial captures…
Don't lose this one
A free account saves cards like this to your Collection, and Korva resurfaces them so you actually remember.